Management of Uncomplicated Recurrent Urinary Tract Infections
Tài liệu tham khảo
Stamey, 1987, Recurrent urinary tract infections in female patients: an overview of management and treatment, Rev Infect Dis, 9, S195, 10.1093/clinids/9.Supplement_2.S195
Vahlensieck, 2015, Therapy strategies in recurrent urinary tract infections [in German], Nieren- und Hochdruckkrkh, 44, 299, 10.5414/NHX01723
O’Grady, 1966, Kinetics of urinary tract infection. II. The bladder, Br J Urol, 38, 156, 10.1111/j.1464-410X.1966.tb09694.x
Kunin, 1997
Hooton, 2001, Recurrent urinary tract infection in women, Int J Antimicrob Agents, 17, 259, 10.1016/S0924-8579(00)00350-2
Dudar, 2009, 12-month comparative study of administration of Canephron® N in the treatment of patients with the urinary tract infection, Health of Man Ukraine, 3, 85
Fuenfstueck, 1997, Prevention of reinfection by L-methionine in patients with recurrent urinary tract infection [in German], Med Klin (Munich), 92, 574
Riedasch, 1986, Immunotherapy in women with recurrent urinary tract infections [in German], Therapiewoche, 6, 896
Raz, 2010, Urinary tract infections in postmenopausal women, 225
Schaeffer, 1999, Efficacy and safety of self-start therapy in women with recurrent urinary tract infections, J Urol, 161, 207, 10.1016/S0022-5347(01)62099-8
L’Agence française de sécurité sanitaire des produits de santé (afssaps). Nitrofurantoïne et risqué de survenue d’effets indésirables hépatiques et pulmonaires lors de traitements prolongés. Pharmacovigilance 2011. Infectiologie Web site. http://www.infectiologie.com/site/medias/_documents/consensus/lp-110311-%20nitrofurantoine.pdf